» Articles » PMID: 11706048

Signal Transducer and Activator of Transcription (Stat) 5 Controls the Proliferation and Differentiation of Mammary Alveolar Epithelium

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2001 Nov 14
PMID 11706048
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

Functional development of mammary epithelium during pregnancy depends on prolactin signaling. However, the underlying molecular and cellular events are not fully understood. We examined the specific contributions of the prolactin receptor (PrlR) and the signal transducers and activators of transcription 5a and 5b (referred to as Stat5) in the formation and differentiation of mammary alveolar epithelium. PrlR- and Stat5-null mammary epithelia were transplanted into wild-type hosts, and pregnancy-mediated development was investigated at a histological and molecular level. Stat5-null mammary epithelium developed ducts but failed to form alveoli, and no milk protein gene expression was observed. In contrast, PrlR-null epithelium formed alveoli-like structures with small open lumina. Electron microscopy revealed undifferentiated features of organelles and a perturbation of cell-cell contacts in PrlR- and Stat5-null epithelia. Expression of NKCC1, an Na-K-Cl cotransporter characteristic for ductal epithelia, and ZO-1, a protein associated with tight junction, were maintained in the alveoli-like structures of PrlR- and Stat5-null epithelia. In contrast, the Na-Pi cotransporter Npt2b, and the gap junction component connexin 32, usually expressed in secretory epithelia, were undetectable in PrlR- and Stat5-null mice. These data demonstrate that signaling via the PrlR and Stat5 is critical for the proliferation and differentiation of mammary alveoli during pregnancy.

Citing Articles

Mechanisms of Regulation of Cell Fate in Breast Development and Cancer.

Van Keymeulen A Adv Exp Med Biol. 2025; 1464():167-184.

PMID: 39821026 DOI: 10.1007/978-3-031-70875-6_10.


STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programs.

Lee H, Chen J, Philips R, Lee S, Feng X, Wu Z bioRxiv. 2025; .

PMID: 39803507 PMC: 11722272. DOI: 10.1101/2024.12.20.629685.


STAT5B SH2 variants disrupt mammary enhancers and the stability of genetic programs during pregnancy.

Lee H, Liu C, Hennighausen L bioRxiv. 2024; .

PMID: 38903072 PMC: 11188103. DOI: 10.1101/2024.05.06.592736.


The Association between the JAK-STAT Pathway and Hypertension among Kenyan Women Diagnosed with Breast Cancer.

Gitau J, Kinyori G, Sayed S, Saleem M, Makokha F, Kirabo A bioRxiv. 2024; .

PMID: 38895458 PMC: 11185763. DOI: 10.1101/2024.06.07.597892.


Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers.

Hathaway C, Rice M, Collins L, Chen D, Frank D, Walker S Breast Cancer Res. 2023; 25(1):24.

PMID: 36882838 PMC: 9990334. DOI: 10.1186/s13058-023-01618-3.


References
1.
Robinson G, McKnight R, Smith G, Hennighausen L . Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development. 1995; 121(7):2079-90. DOI: 10.1242/dev.121.7.2079. View

2.
DANIEL C, Strickland P, Friedmann Y . Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol. 1995; 169(2):511-9. DOI: 10.1006/dbio.1995.1165. View

3.
Pozzi A, Risek B, Kiang D, Gilula N, Kumar N . Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp Cell Res. 1995; 220(1):212-9. DOI: 10.1006/excr.1995.1308. View

4.
Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C . Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 1995; 9(19):2364-72. DOI: 10.1101/gad.9.19.2364. View

5.
Gumbiner B . Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996; 84(3):345-57. DOI: 10.1016/s0092-8674(00)81279-9. View